These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 379253)

  • 1. Newer antiarrhythmic drugs.
    Dhurandhar RW; Bhansali SK
    J La State Med Soc; 1979 Apr; 131(4):102-8. PubMed ID: 379253
    [No Abstract]   [Full Text] [Related]  

  • 2. Bretylium: a prototype for future development of antidysrhythmic agents.
    Patterson E; Lucchesi BR
    Am Heart J; 1983 Aug; 106(2):426-31. PubMed ID: 6869235
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiarrhythmic therapy: new additions and future expectations.
    Ross WB; Mohiuddin SM
    Geriatrics; 1983 Jan; 38(1):30-5. PubMed ID: 6184263
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of the Na,K-ATPase by the antiarrhythmic drug, Bretylium.
    Gatto C; Barkulis CT; Schneider WR; Holden JP; Arnett KL; Milanick MA
    Ann N Y Acad Sci; 2003 Apr; 986():620-2. PubMed ID: 12763901
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs with a class III antiarrhythmic action.
    Bexton RS; Camm AJ
    Pharmacol Ther; 1982; 17(3):315-55. PubMed ID: 6761715
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of antiarrhythmic drugs in prevention of sudden cardiac death.
    Podrid PJ
    Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903
    [No Abstract]   [Full Text] [Related]  

  • 7. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death.
    Johnson GL; Ehrreich SJ; el-Hage AN; Balazs T
    Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):351-64. PubMed ID: 3704313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the electrophysiological properties of bretylium tosylate in man].
    Touboul P; Porte J; Huerta F; Delahaye JP
    Arch Mal Coeur Vaiss; 1976 May; 69(5):503-11. PubMed ID: 821420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane perturbational effects of antiarrhythmic drugs.
    Godin DV; Au T; Garnett ME
    J Mol Cell Cardiol; 1979 Mar; 11(3):261-74. PubMed ID: 423266
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of antiarrhythmic drugs by sudden death trials.
    Fisher LD
    Circulation; 1986 Feb; 73(2 Pt 2):II98-100. PubMed ID: 3510770
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents.
    Ellrodt G; Singh BN
    Heart Lung; 1980; 9(3):469-74. PubMed ID: 6901519
    [No Abstract]   [Full Text] [Related]  

  • 14. Negative inotropic effects of antiarrhythmic drugs: a clinical point of view.
    Pfisterer M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S44-7. PubMed ID: 1723118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
    Seipel L; Breithardt G; Both A
    Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs.
    Hasannejad H; Takeda M; Narikawa S; Huang XL; Enomoto A; Taki K; Niwa T; Jung SH; Onozato ML; Tojo A; Endou H
    Eur J Pharmacol; 2004 Sep; 499(1-2):45-51. PubMed ID: 15363950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of old and new antiarrhythmic drugs.
    Siddoway LA; Roden DM; Woosley RL
    Cardiovasc Clin; 1985; 15(3):199-248. PubMed ID: 2870805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives in cardiology: pharmacodynamic classification of antiarrhythmic drugs.
    Adams HR
    J Am Vet Med Assoc; 1986 Sep; 189(5):525-32. PubMed ID: 2875984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs for treatment of ventricular arrhythmias.
    Heger JJ; Prystowsky EN; Zipes DP
    Heart Lung; 1981; 10(3):475-83. PubMed ID: 6785255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.